Cargando…
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19
BACKGROUND: People suffering from COVID‐19 are typically considered non‐infectious 14 days after diagnosis if symptoms have disappeared for at least 48 h. We describe three patients who independently acquired their infection. These three patients experienced mild COVID‐19 and completely recovered sy...
Autores principales: | Zahn, Tobias, Mhedhbi, Ines, Hein, Sascha, Raupach, Jan, Miskey, Csaba, Husria, Younes, Bayanga, Kathrin, Bartel, Detlef, Vieths, Stefan, Ivics, Zoltan, Oberle, Doris, Keller‐Stanislawski, Brigitte, Herrlein, Marie‐Luise, Maier, Thorsten Jürgen, Hildt, Eberhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652783/ https://www.ncbi.nlm.nih.gov/pubmed/34637150 http://dx.doi.org/10.1111/all.15138 |
Ejemplares similares
-
Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination
por: Hein, Sascha, et al.
Publicado: (2022) -
Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
por: Herrlein, Marie-Luise, et al.
Publicado: (2022) -
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021) -
The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
por: Hastert, Florian D., et al.
Publicado: (2022) -
The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response
por: Hein, Sascha, et al.
Publicado: (2023)